An American medical charity is now worth billions of dollars after making a hugely successful investment in a drug to treat the deadly disease cystic fibrosis.
The arrangement has raised some concerns about the relationship between charities and big business, but as John Clarke reports, it could become a model for the way charities operate in the future
IN: "Cystic fibrosis...
OUT: SOC
DUR: 44"